U. Rauch et al., MAPPING OF A DEFINED NEUROCAN BINDING-SITE TO DISTINCT DOMAINS OF TENASCIN-C, The Journal of biological chemistry, 272(43), 1997, pp. 26905-26912
Neurocan is a member of the aggrecan family of proteoglycans which are
characterized by NH2-terminal domains binding hyaluronan, and COOH-te
rminal domains containing C type lectin like modules, To detect and en
hance the affinity for complementary ligands of neurocan, the COOH ter
minal neurocan domain was fused with the NH2-terminal region of tenasc
in-C, which contains the hexamerization domain of this extracellular m
atrix glycoprotein, The fusion protein was designed to contain the las
t downstream glycosaminoglycan attachment site and was expressed as a
proteoglycan, In ligand overlay blots carried out with brain extracts,
it recognized tenascin-C. The interaction was abolished by the additi
on of EDTA, or TNfn4,5, a bacterially expressed tenascin-C fragment co
mprising the fourth and fifth fibronectin type III module, The fusion
protein directly reacted with this fragment in ligand blot and enzyme
linked immunosorbent assay procedures, Both tenascin-C and TNfn4,5 wer
e retained on Sepharose 4B-linked carboxyl-terminal neurocan domains,
which in BIAcore binding studies yielded a K-D value of 17 nM for puri
fied tenascin-C, We conclude that a divalent cation-dependent interact
ion between the COOH-terminal domain of neurocan and those fibronectin
type III repeats is substantially involved in the binding of neurocan
to tenascin-C.